Leadership & Pay ·
United Therapeutics Corporation increased its Board of Directors to 13 members following the appointment of Victor…
UTHRUNITED THERAPEUTICS Corp
United Therapeutics Corporation increased its Board of Directors to 13 members following the appointment of Victor Dzau, M.D., effective July 22, 2026. Dr. Dzau, formerly President of the National Academy of Medicine, received 380 restricted stock units and 1,190 stock options as an initial grant, plus pro-rata grants of 350 restricted stock units and 1,110 stock options for the remainder of the 2026-2027 service year. The appointment is part of a board refreshment effort. United Therapeutics is a biotechnology company focused on developing treatments for rare diseases and organ alternatives.